CVR: 26791413
Secondary names: VISION A/S
Previous names: GFKJURA 947 A/S, GUDME RAASCHOU BALANCED GROWTH A/S, GUDME RAASCHOU VISION A/S
Pharma Equity Group A/S is a Danish company of the type Aktieselskab based in Hørsholm, founded in 2002. The company is registered under the industry Investering for egen regning. The company was previously named BLUE VISION A/S and GUDME RAASCHOU VISION A/S. The management consists of Christian Henrik Tange. The company's owners include NIELS ERIK JESPERSEN HOLDING ApS, Beier Holding ApS and FINANSMANAGEMENT ApS. The company has 0 employees. In 2025, the company reported revenue of DKK 0. Equity amounted to DKK 25,472,000.
Your company? Claim the profile and show your logo, website and social channels — for free.
Claim this profileSelskabets formål er uden geografisk begrænsning at være holdingselskab for selskaber med Life Science virksomhed samt at investere i aktier optaget til handel på en reguleret markedsplads eller multilateral handelsfacilitet og ikke noterede kapitalandele efter bestyrelsens nærmere bestemmelse med henblik på at opnå langsigtet værditilvækst under iagttagelse af passende risikospredning samt anden i forbindelse dermed stående virksomhed.
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2025 | 0 | - | 38.9 mio. | 25.5 mio. | 5 | |
| 2024 | 0 | -24.4 mio. | 65.6 mio. | 48.9 mio. | - | |
| 2023 | 0 | -24.6 mio. | 81.3 mio. | 38.9 mio. | - | |
| 2022 | - | 3.5 mio. | 71.1 mio. | 46 mio. | - | |
| 2021 | - | 5.4 mio. | 63.6 mio. | 42.6 mio. | - | |
| 2020 | - | -32.9 mio. | 57.6 mio. | 34.3 mio. | - | |
| 2019 | - | -14.4 mio. | 72.4 mio. | 67.2 mio. | - | |
| 2018 | - | -7.7 mio. | 80.8 mio. | 77.6 mio. | - | |
| 2017 | - | -4.1 mio. | 124.9 mio. | 103.3 mio. | - | |
| 2016 | - | -2 mio. | 125.8 mio. | 96.8 mio. | - | |
| 2015 | - | -3.7 mio. | 126.3 mio. | 99.5 mio. | - | |
| 2014 | 0 | -5.9 mio. | 124 mio. | 98 mio. | - |
Daily closing prices, Nasdaq Copenhagen
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringCompared to 8.488 companies in Investering for egen regning
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Pharma Equity Group A/S has published its annual report for 2025.
Contact info changed: new email: [email protected], new website: www.pharmaequitygroup.com (April 29, 2026).
As of April 16, 2026, Troels Peter Troelsen has left the board of directors of Pharma Equity Group A/S.
As of April 16, 2026, Peter Vilmann has left the board of directors of Pharma Equity Group A/S.
Address changed to Slotsmarken 12 1. th 12, 1 th, 2970 Hørsholm (January 19, 2026).
Contact info changed: new email: [email protected], new website: www.pharmaequitygroup.com (January 19, 2026).
Pharma Equity Group A/S has published its interim report for the period January 1, 2025 – June 30, 2025.
As of August 12, 2025, BDO Statsautoriseret Revisionspartnerselskab has been appointed auditor of Pharma Equity Group A/S.
As of August 12, 2025, A/S PSE 17 NR. 1056 has stepped down as auditor of Pharma Equity Group A/S.
Pharma Equity Group A/S has published its annual report for 2024. Revenue came to DKK 0, and the net result was DKK -24,422,000.
As of April 16, 2025, Troels Peter Troelsen has joined the board of directors of Pharma Equity Group A/S.
As of April 16, 2025, Charlotte Pahl has joined the board of directors of Pharma Equity Group A/S.
As of April 1, 2025, Christian Henrik Tange is registered as adm. dir. of Pharma Equity Group A/S.
As of April 1, 2025, Thomas Kaas Selsø has stepped down as adm. dir. of Pharma Equity Group A/S.
As of November 29, 2024, Martin Engell-Rossen has left the board of directors of Pharma Equity Group A/S.
Pharma Equity Group A/S has published its interim report for the period January 1, 2024 – September 30, 2024.
As of October 11, 2024, DMZ HOLDING ApS is registered as an owner of Pharma Equity Group A/S with an ownership share of 10%.
Pharma Equity Group A/S has published its interim report for the period January 1, 2024 – June 30, 2024.
As of July 11, 2024, FINANSMANAGEMENT ApS is registered as an owner of Pharma Equity Group A/S with an ownership share of 15%.
Pharma Equity Group A/S has published its interim report for the period January 1, 2024 – March 31, 2024.
Pharma Equity Group A/S has published its annual report for 2023. Revenue came to DKK 0, and the net result was DKK -24,609,000.
Pharma Equity Group A/S has published its interim report for the period January 1, 2023 – September 30, 2023.
As of November 2, 2023, Martin Engell-Rossen has joined the board of directors of Pharma Equity Group A/S.
As of November 2, 2023, Omar Siraj M Qandeel has joined the board of directors of Pharma Equity Group A/S.
Pharma Equity Group A/S has published its interim report for the period January 1, 2023 – June 30, 2023.
As of June 15, 2023, Christian Vinding Thomsen has joined the board of directors of Pharma Equity Group A/S.
As of June 15, 2023, Peter Mørch Eriksen has left the board of directors of Pharma Equity Group A/S.
As of June 15, 2023, Ole Larsen has left the board of directors of Pharma Equity Group A/S.
As of June 14, 2023, Christian Vinding Thomsen has left the board of directors of Pharma Equity Group A/S.
Pharma Equity Group A/S has published its interim report for the period January 1, 2023 – March 31, 2023.
Pharma Equity Group A/S has published its annual report for 2022. The net result was DKK 3,479,000.
As of April 27, 2023, Peter Vilmann has joined the board of directors of Pharma Equity Group A/S.
As of April 27, 2023, Mette Zacho has left the board of directors of Pharma Equity Group A/S.
As of March 31, 2023, Lars Rosenkrantz Gundorph has joined the board of directors of Pharma Equity Group A/S.
As of March 31, 2023, Peter Mørch Eriksen has joined the board of directors of Pharma Equity Group A/S.
As of March 31, 2023, Christian Vinding Thomsen has joined the board of directors of Pharma Equity Group A/S.
As of March 31, 2023, Ole Larsen has joined the board of directors of Pharma Equity Group A/S.
As of March 31, 2023, Mette Zacho has joined the board of directors of Pharma Equity Group A/S.
As of March 31, 2023, Claus Abildstrøm has left the board of directors of Pharma Equity Group A/S.
As of March 31, 2023, Peter Ole Jensen has left the board of directors of Pharma Equity Group A/S.
As of March 31, 2023, Thomas Kaas Selsø is registered as adm. dir. of Pharma Equity Group A/S.
As of March 31, 2023, Peter Ole Jensen has stepped down as adm. dir. of Pharma Equity Group A/S.
As of March 30, 2023, Peter Mørch Eriksen has left the board of directors of Pharma Equity Group A/S.
As of March 24, 2023, NIELS ERIK JESPERSEN HOLDING ApS is registered as an owner of Pharma Equity Group A/S with an ownership share of 5%.
As of March 24, 2023, Beier Holding ApS is registered as an owner of Pharma Equity Group A/S with an ownership share of 5%.
As of February 10, 2023, A/S PSE 17 NR. 1056 has been appointed auditor of Pharma Equity Group A/S.
As of February 10, 2023, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of Pharma Equity Group A/S.
On February 10, 2023, the company changed its name from BLUE VISION A/S to Pharma Equity Group A/S.
Pharma Equity Group A/S has published its interim report for the period January 1, 2022 – June 30, 2022.
Pharma Equity Group A/S has published its annual report for 2021. The net result was DKK 5,391,000.
As of April 27, 2022, Peter Ole Jensen is registered as adm. dir. of Pharma Equity Group A/S.
As of April 27, 2022, Jeanette Gyldstoff Borg has stepped down as adm. dir. of Pharma Equity Group A/S.
As of April 25, 2022, Claus Abildstrøm has joined the board of directors of Pharma Equity Group A/S.
As of April 25, 2022, Peter Mørch Eriksen has joined the board of directors of Pharma Equity Group A/S.
As of April 25, 2022, Peter Ole Jensen has joined the board of directors of Pharma Equity Group A/S.
As of April 25, 2022, Jeanette Gyldstoff Borg has left the board of directors of Pharma Equity Group A/S.
As of April 24, 2022, Claus Abildstrøm has left the board of directors of Pharma Equity Group A/S.
As of April 24, 2022, Peter Ole Jensen has left the board of directors of Pharma Equity Group A/S.
Pharma Equity Group A/S has published its interim report for the period January 1, 2021 – June 30, 2021.
Pharma Equity Group A/S has published its annual report for 2020. The net result was DKK -32,875,000.
Pharma Equity Group A/S has published its annual report for 2019. The net result was DKK -14,417,000.
As of December 31, 2020, Jeanette Gyldstoff Borg has joined the board of directors of Pharma Equity Group A/S.
As of December 31, 2020, Peter Ole Jensen has joined the board of directors of Pharma Equity Group A/S.
As of December 31, 2020, Jeanette Gyldstoff Borg is registered as adm. dir. of Pharma Equity Group A/S.
As of December 31, 2020, Peter Miro Hauge Jensen has stepped down as adm. dir. of Pharma Equity Group A/S.
As of December 22, 2020, Rolf Gordon Adamson has left the board of directors of Pharma Equity Group A/S.
As of June 15, 2020, Ulrik Feldstedt Hjorth has left the board of directors of Pharma Equity Group A/S.
As of June 15, 2020, Nicolai Dines Kærgaard has left the board of directors of Pharma Equity Group A/S.
As of January 8, 2020, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of Pharma Equity Group A/S.
As of December 9, 2019, BAKER TILLY DENMARK GODKENDT REVISIONSAKTIESELSKAB has stepped down as auditor of Pharma Equity Group A/S.
Pharma Equity Group A/S has published its interim report for the period January 1, 2019 – June 30, 2019.
As of September 30, 2019, Ulrik Feldstedt Hjorth has joined the board of directors of Pharma Equity Group A/S.
As of September 30, 2019, Rolf Gordon Adamson has joined the board of directors of Pharma Equity Group A/S.
As of September 30, 2019, Peer Henning Borg has left the board of directors of Pharma Equity Group A/S.
As of September 30, 2019, Peter Miro Hauge Jensen is registered as adm. dir. of Pharma Equity Group A/S.
As of September 30, 2019, Peer Henning Borg has stepped down as adm. dir. of Pharma Equity Group A/S.
Pharma Equity Group A/S has published its annual report for 2018. The net result was DKK -7,713,000.
As of April 26, 2019, Morten Søndergaard Schwensen has stepped down as auditor of Pharma Equity Group A/S.
Pharma Equity Group A/S has published its interim report for the period January 1, 2018 – June 30, 2018.
Pharma Equity Group A/S has published its annual report for 2017. The net result was DKK -4,077,000.
As of April 30, 2018, Morten Søndergaard Schwensen has been appointed auditor of Pharma Equity Group A/S.
As of April 30, 2018, Peter Aagesen has been appointed auditor of Pharma Equity Group A/S.
As of April 30, 2018, BAKER TILLY DENMARK GODKENDT REVISIONSAKTIESELSKAB has been appointed auditor of Pharma Equity Group A/S.
As of April 30, 2018, Peter Aagesen has stepped down as auditor of Pharma Equity Group A/S.
As of April 30, 2018, KPMG P/S has stepped down as auditor of Pharma Equity Group A/S.
As of April 30, 2018, Peer Henning Borg has joined the board of directors of Pharma Equity Group A/S.
As of April 30, 2018, Nicolai Dines Kærgaard has joined the board of directors of Pharma Equity Group A/S.
As of April 30, 2018, Niels Troen has left the board of directors of Pharma Equity Group A/S.
As of April 30, 2018, Gert Michael Mortensen has left the board of directors of Pharma Equity Group A/S.
As of April 30, 2018, Peer Thomas Borg has left the board of directors of Pharma Equity Group A/S.
Pharma Equity Group A/S has published its interim report for the period January 1, 2017 – June 30, 2017.
As of October 25, 2017, Claus Abildstrøm has joined the board of directors of Pharma Equity Group A/S.
As of October 25, 2017, Niels Troen has joined the board of directors of Pharma Equity Group A/S.
As of October 25, 2017, Niels Troen is registered as adm. dir. of Pharma Equity Group A/S.
As of October 25, 2017, Niels Troen has stepped down as adm. dir. of Pharma Equity Group A/S.
As of October 24, 2017, Claus Abildstrøm has left the board of directors of Pharma Equity Group A/S.
As of October 24, 2017, Niels Troen has left the board of directors of Pharma Equity Group A/S.
As of August 16, 2017, Peer Henning Borg is registered as adm. dir. of Pharma Equity Group A/S.
As of August 16, 2017, Peer Henning Borg has stepped down as adm. dir. of Pharma Equity Group A/S.
Pharma Equity Group A/S has published its annual report for 2016. The net result was DKK -2,015,000.
As of June 29, 2016, Christian Gersdorff Stenbjerre has left the board of directors of Pharma Equity Group A/S.
Pharma Equity Group A/S has published its annual report for 2015. The net result was DKK -3,742,000.
As of February 18, 2016, Niels Troen has joined the board of directors of Pharma Equity Group A/S.
As of February 18, 2016, Leif Reinholdt Erlandsen has left the board of directors of Pharma Equity Group A/S.
As of December 30, 2015, Peer Henning Borg is registered as adm. dir. of Pharma Equity Group A/S.
As of December 30, 2015, Staffan Mattson has stepped down as adm. dir. of Pharma Equity Group A/S.
Pharma Equity Group A/S has published its annual report for 2014. Revenue came to DKK 0, and the net result was DKK -5,930,000.
As of March 27, 2015, Leif Reinholdt Erlandsen has joined the board of directors of Pharma Equity Group A/S.
As of March 27, 2015, Christian Gersdorff Stenbjerre has joined the board of directors of Pharma Equity Group A/S.
As of March 27, 2015, Claus Abildstrøm has joined the board of directors of Pharma Equity Group A/S.
As of March 26, 2015, Claus Abildstrøm has left the board of directors of Pharma Equity Group A/S.
As of February 2, 2015, KPMG P/S has been appointed auditor of Pharma Equity Group A/S.
As of February 2, 2015, EY Godkendt Revisionspartnerselskab has stepped down as auditor of Pharma Equity Group A/S.
As of July 11, 2014, Staffan Mattson is registered as adm. dir. of Pharma Equity Group A/S.
As of July 11, 2014, Morten Jensen has stepped down as adm. dir. of Pharma Equity Group A/S.
Pharma Equity Group A/S has published its annual report for 2013.
As of April 30, 2014, Claus Abildstrøm has joined the board of directors of Pharma Equity Group A/S.
As of April 30, 2014, Gert Michael Mortensen has joined the board of directors of Pharma Equity Group A/S.
As of April 30, 2014, Peer Thomas Borg has joined the board of directors of Pharma Equity Group A/S.
As of April 30, 2014, Frederik Steen Westenholz has left the board of directors of Pharma Equity Group A/S.
As of April 30, 2014, Vilhelm Boas has left the board of directors of Pharma Equity Group A/S.
As of April 30, 2014, Henrik Faber Andersen has left the board of directors of Pharma Equity Group A/S.
As of April 30, 2014, Morten Jensen is registered as adm. dir. of Pharma Equity Group A/S.
As of April 30, 2014, Vilhelm Boas has stepped down as director of Pharma Equity Group A/S.
Pharma Equity Group A/S has published its annual report for 2012.
As of April 30, 2013, Vilhelm Boas has joined the board of directors of Pharma Equity Group A/S.
As of April 30, 2013, Martin Blædel has left the board of directors of Pharma Equity Group A/S.
As of April 30, 2013, Lars Fogh has left the board of directors of Pharma Equity Group A/S.
As of April 30, 2013, Jørgen Glistrup has left the board of directors of Pharma Equity Group A/S.
As of April 30, 2012, Martin Blædel has joined the board of directors of Pharma Equity Group A/S.
As of October 7, 2011, Frederik Steen Westenholz has joined the board of directors of Pharma Equity Group A/S.
As of October 7, 2011, Jørgen Glistrup has joined the board of directors of Pharma Equity Group A/S.
As of October 7, 2011, Martin Blædel has left the board of directors of Pharma Equity Group A/S.
As of October 7, 2011, Thomas Hénin Falk-Rønne has left the board of directors of Pharma Equity Group A/S.
As of April 29, 2011, Lars Fogh has joined the board of directors of Pharma Equity Group A/S.
As of April 29, 2011, Henrik Faber Andersen has joined the board of directors of Pharma Equity Group A/S.
As of December 18, 2009, Thomas Hénin Falk-Rønne has joined the board of directors of Pharma Equity Group A/S.
As of December 18, 2009, Lachlan Williams has left the board of directors of Pharma Equity Group A/S.
As of November 4, 2009, Martin Blædel has joined the board of directors of Pharma Equity Group A/S.
As of November 4, 2009, Lachlan Williams has joined the board of directors of Pharma Equity Group A/S.
As of November 4, 2009, Michael Vilhelm Nielsen has left the board of directors of Pharma Equity Group A/S.
As of November 4, 2009, Flemming Hinsch Jensen has left the board of directors of Pharma Equity Group A/S.
As of November 4, 2009, Niels Mazanti has left the board of directors of Pharma Equity Group A/S.
On November 4, 2009, the company changed its name from GUDME RAASCHOU VISION A/S to BLUE VISION A/S.
As of June 3, 2009, Vilhelm Boas is registered as director of Pharma Equity Group A/S.
As of June 3, 2009, David Ying Shen Huang has stepped down as director of Pharma Equity Group A/S.
As of April 27, 2009, EY Godkendt Revisionspartnerselskab has been appointed auditor of Pharma Equity Group A/S.
As of April 27, 2009, REVISIONS- OG FORVALTNINGS- INSTITUTET, AKTIESELSKAB has stepped down as auditor of Pharma Equity Group A/S.
As of April 22, 2008, Michael Vilhelm Nielsen has joined the board of directors of Pharma Equity Group A/S.
As of April 22, 2008, Flemming Hinsch Jensen has joined the board of directors of Pharma Equity Group A/S.
As of April 22, 2008, Niels Mazanti has joined the board of directors of Pharma Equity Group A/S.
As of April 22, 2008, Thomas David Hartwig has left the board of directors of Pharma Equity Group A/S.
As of April 22, 2008, Kjeld Bjarne Skov has left the board of directors of Pharma Equity Group A/S.
As of April 22, 2008, Hans-Henrik Horsted Eriksen has left the board of directors of Pharma Equity Group A/S.
As of April 26, 2007, REVISIONS- OG FORVALTNINGS- INSTITUTET, AKTIESELSKAB has been appointed auditor of Pharma Equity Group A/S.
As of April 26, 2007, ADR NR. 1850 ApS has stepped down as auditor of Pharma Equity Group A/S.
As of April 26, 2007, Pricewaterhouse Coopers has stepped down as auditor of Pharma Equity Group A/S.
As of April 26, 2006, Hans-Henrik Horsted Eriksen has joined the board of directors of Pharma Equity Group A/S.
As of April 26, 2006, Jakob Schmidt has left the board of directors of Pharma Equity Group A/S.
As of May 19, 2003, Thomas David Hartwig has joined the board of directors of Pharma Equity Group A/S.
As of May 19, 2003, Jakob Schmidt has joined the board of directors of Pharma Equity Group A/S.
On May 13, 2003, the company changed its name from GUDME RAASCHOU BALANCED GROWTH A/S to GUDME RAASCHOU VISION A/S.
As of May 2, 2003, ADR NR. 1850 ApS has been appointed auditor of Pharma Equity Group A/S.
As of May 2, 2003, Pricewaterhouse Coopers has been appointed auditor of Pharma Equity Group A/S.
As of May 2, 2003, REVISIONS- OG FORVALTNINGS- INSTITUTET, AKTIESELSKAB has stepped down as auditor of Pharma Equity Group A/S.
As of May 2, 2003, Kjeld Bjarne Skov has joined the board of directors of Pharma Equity Group A/S.
As of May 2, 2003, Klaus Søgaard has left the board of directors of Pharma Equity Group A/S.
As of May 2, 2003, Jan-Erik Gunnar Svensson has left the board of directors of Pharma Equity Group A/S.
As of May 2, 2003, Troels Elkiær Andersen has left the board of directors of Pharma Equity Group A/S.
As of May 2, 2003, David Ying Shen Huang is registered as director of Pharma Equity Group A/S.
As of May 2, 2003, Klaus Søgaard has stepped down as director of Pharma Equity Group A/S.
On May 2, 2003, the company changed its name from GFKJURA 947 A/S to GUDME RAASCHOU BALANCED GROWTH A/S.
As of September 20, 2002, REVISIONS- OG FORVALTNINGS- INSTITUTET, AKTIESELSKAB has been appointed auditor of Pharma Equity Group A/S.
As of September 20, 2002, Klaus Søgaard has joined the board of directors of Pharma Equity Group A/S.
As of September 20, 2002, Jan-Erik Gunnar Svensson has joined the board of directors of Pharma Equity Group A/S.
As of September 20, 2002, Troels Elkiær Andersen has joined the board of directors of Pharma Equity Group A/S.
As of September 20, 2002, Klaus Søgaard is registered as director of Pharma Equity Group A/S.
Pharma Equity Group A/S was founded on September 20, 2002.
Companies in the same industry and area
CVR 42386308
CVR 46190041
CVR 38715445
CVR 44196573
CVR 63012513
companydata.dk